Empagliflozin reduced HbA1c, fasting plasma glucose and body weight when administered alone or as an add-on to metformin in patients with type 2 diabetes….  Adults with type 2 diabetes who had participated in one of two 12-week studies of empagliflozin (Boehringer Ingelheim, Eli Lilly) were treated for an additional 78 …

A nurse-led telephone intervention program for patients with diabetes resulted in a significant reduction in HbA1c levels, with successfully treated patients reporting reductions of more than 3.0% from baseline….

The higher the A1c the more cognitive decline was found, which means that having diabetes and poor glucose control may put older patients on a faster path to cognitive impairment….

Sitagliptin yielded similar glycemic results as sulfonylureas, but with less hypoglycemia and improvements in body weight among elderly patients with type 2 diabetes….

Psoriasis, especially more severe cases, may raise the risk of developing diabetes, a population-based study determined…. 

According to a large study to demonstrate a potential link, the most common type of obesity surgery may increase patients’ chances for alcohol abuse…. 

Initiating intensive therapy in treatment-naive, newly-diagnosed patients with type 2 diabetes preserved beta-cell function for 3.5 years….

In patients with type 2 diabetes taking metformin, vitamin B12 deficiency is associated with higher levels of peripheral neuropathy….

Stone fruits, also known as drupes, such as nectarines, plums and peaches, may contain useful compounds that help fight-off metabolic syndrome…. 

The risk of developing type 2 diabetes was as much as 24% lower among people with a diet rich in selenium….